Trans-Omics Biomarker Model Improves Prognostic Prediction Accuracy for Early-Stage Lung Adenocarcinoma

Aging - United States
doi 10.18632/aging.102189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Impact Journals, LLC

Related search

DNA Hypomethylation-Related Overexpression of SFN, GORASP2 and ZYG11A Is a Novel Prognostic Biomarker for Early Stage Lung Adenocarcinoma

Oncotarget
Oncology
2019English

Classification and Survival Prediction for Early‑stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients

Oncology Letters
Cancer ResearchOncology
2017English

Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma

Polish Journal of Pathology
MedicineForensic MedicinePathology
2018English

MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2019English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

P3.16-06 Does Comprehensive Mutation Analysis Add Prognostic Value in Resected Early Stage Lung Adenocarcinoma?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P032 Integrin Subunit Alpha 5: Potential Prognostic Biomarker in Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Left Lung Torsion: Complication of Lobar Resection for an Early Stage Lung Adenocarcinoma

Case Reports in Critical Care
2016English

Prognostic Potential of theMDM2309T>G Polymorphism in Stage I Lung Adenocarcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy